In EGCG-treated mice, histological evaluation revealed decreased hepatic steatosis, steatohepatitis activity, and liver inflammation, accompanied by lower serum ALT and AST levels—markers of liver function. The gene discussed is GPT; the disease is Hepatic steatosis.